Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Health Economics & Costs

Monday Links

Posted on July 18, 2022July 25, 2022 by John C. Goodman
  • Prices that aren’t rising: drugs. In fact, they are falling.
  • If global warming is bad for health, why do so few people die from excessive heat in India and Pakistan?
  • BA.5 doesn‘t care if you’ve just had Covid-19.
  • US men have the highest rate of avoidable deaths among developed countries. The Commonwealth Foundation blames capitalism.
  • Paragon study: Insulin bill would raise costs, add to the federal deficit and hurt patients.
  • Health care CEOs are doing well:  more than 100 of them pulled in at least eight figures last year.
+

House GOP Health Task Force Way Too Timid

Posted on July 17, 2022 by John C. Goodman

The plan is here.

Hate to be a killjoy but this is sort of like being in a fox hole and no one mentions there are bullets flying overhead. Why is it so difficult for Republicans to address the voters’ most basic problems? Like this:

  1. People should be able to buy insurance that meets their financial and health care needs– as an alternative to the outrageous deductibles and unaffordable premiums in the Democrat-created health insurance exchange plans.
  2. People with serious health problems should be able to buy insurance that gives them access to the doctors they need— as an alternative to the narrow provider networks in the Democrat-created health insurance exchange plans.
+

New Antibiotics Are Desperately Needed: Why Drug Makers Won’t Develop Them

Posted on July 15, 2022 by Devon Herrick

Antibiotic-resistant bacterial infections are a growing. Worse yet, the pipeline of new antibiotic drugs in development are few and far between. It’s been several years since the U.S. Food and Drug Administration (FDA) approved a new antibiotic. The FDA recently declined to approve two new applications for drugs to treat urinary tract infections (sulopenem and tebipenem). The agency wants more data on the efficacy compared to drugs currently on the market. It’s not likely to get better anytime soon.

+

Diet or Exercise: It Not Either / Or, It’s Both

Posted on July 14, 2022 by Devon Herrick

Do you like to dine on a meal of McDonald’s Big Macs and supersized fries? Maybe you like desserts like fried pies a little too much. Perhaps you think that jogging to McDonalds and back after eating a Big Mac will atone for your poor diet. According to experts it won’t.

+
  • Previous
  • 1
  • …
  • 341
  • 342
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 368
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom